CHP/PCOR Publications

Commentary on "Enoxaparin had Lower Costs Than Unfractionated Heparin for Acute Coronary Syndrome"

Commentary

Author
Mark A. Hlatky - Stanford University

Published by
ACP J Club, Vol. 129, page(s) 80
November-December, 1998

Reprinted in Evidence-Based Med 1998 Nov-Dec;3:193.

Publications of interest

Low Molecular Weight Heparins Compared with Unfractionated Heparin for the Treatment of Acute Deep Vein Thrombosis: A Cost-Effectiveness Analysis
Michael K. Gould, Anne Dembitzer, Gillian D. Sanders, Alan M. Garber
Annals of Internal Medicine vol. 130 (1999)
Commentary on "Rt-PA Plus Heparin or Low Dose Aspirin for Acute Myocardial Infarction?"
Mark A. Hlatky
Annals of Internal Medicine vol. 114, suppl 2 (1991)
Commentary on "Immediate Angioplasty was Better Than Streptokinase in Acute MI"
Mark A. Hlatky
Annals of Internal Medicine vol. 121, Suppl 2 (1994)
Commentary on "Low-Molecular-Weight Heparin was Cost Effective for Perioperative Prevention of DVT"
Douglas K. Owens
ACP Journal Club vol. 126 (1997)